Franjo Grotenhermen – "Interactions of cannabinoids with other drugs" – PMC19 Lisbon Videoconference
Dr. Franjo Grotenhermen presents “Interactions of cannabinoids with other drugs”
Cannabis, THC and CBD may interact with other medicinal drugs. Some of these interactions may be of medicinal value, for example increase of pain reduction by THC and opioids, while others may be unwanted, such as uncontrolled influence on blood concentrations of other antiepileptic drugs.
Interactions of THC and CBD may be divided into pharmacokinetic interactions (usually based on degradation issues) and pharmacodynamic interactions (usually based on the effects of CBD and THC on the one hand and other medications on the other hand.
Medical Doctor — German Association for cannabis as Medicine (ACM)
Franjo Grotenhermen studied medicine in Cologne, Germany, before achieving the title of Doctor of Medicine with the grade “”summa cum laude””. His clinical work was in the fields of internal medicine, surgery and naturopathic medicine. His medical practice is in Rüthen (North Rhine-Westphalia), with particular focus on naturopathic techniques and therapy using cannabis and cannabinoids. Grotenhermen is the president of the Cannabis as Medicine working group (ACM), founded in 1997, and managing director of the International Association for Cannabinoids Medicine working group (IACM). He publishes the IACM newsletter in six languages as well as the magazine Cannabinoids. Grotenhermen works at the Nova-Institute in Cologne and is the author of many articles and books on the therapeutic potential of hemp plants, cannabinoids and their pharmacology and toxicology. He is an expert in these fields for private individuals, pharmaceutical firms, law courts and international institutions.”